Count | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 15 | |
| 3 | |
| 3 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 335 | |
| 20 | |
Recombinant Proteins/administration & dosage/blood/therapeutic use | 1 |
Recombinant Proteins/administration & dosage/blood/pharmacology | 2 |
Recombinant Proteins/administration & dosage/blood/pharmacokinetics | 4 |
Recombinant Proteins/analysis/blood/isolation & purification | 1 |
Recombinant Fusion Proteins/biosynthesis/blood/therapeutic use | 1 |
Recombinant Proteins/blood/genetics/isolation & purification | 2 |
| 1 | |
| 1 | |
| 3 | |
| 4 | |
| 14 | |
| 28 | |
| 36 | |
| 1 | |
| 3 | |
| 25 | |
| 1 | |
| 1 | |
| 103 | |
| 1 | |
| 45 | |
| 1 | |
| 10 | |
| 1 | |
| 22 | |
| 1 | |
| 21 | |
Recombinant Fusion Proteins/adverse effects/blood/*therapeutic use | 1 |
Recombinant Proteins/administration & dosage/adverse effects/blood | 1 |
Recombinant Proteins/administration & dosage/blood/chemistry/genetics | 1 |
Recombinant Fusion Proteins/administration & dosage/blood/therapeutic use | 1 |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 11 | |
| 10 | |
| 6 | |
| 1 | |
| 2 | |
| 3 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 3 | |
| 9 | |
| 7 | |
| 12 | |
| 1 | |
| 21 | |
| 1 | |
| 1 | |
| 7 | |
| 6 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 2 | |